ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentMelideMogon Pharmaceuticals Sagl
Mogon Pharmaceuticals Sagl Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Mogon Pharmaceuticals Sagl consists in the development and provision of solutions for drug delivery, particularly through the development of technology platforms for controlled drug delivery, including immediate and modified release systems for oral applications.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
No score yet

Mogon Pharmaceuticals Sagl

Pharmaceutical Industry
✓ Offered6
Drug Delivery Systems
Drug delivery system solutions with technology platforms for targeting, timing and dosing of drug substances; development support from drug development to commercial launch.
Technologie IOR
Immediate release therapeutic system to improve oral bioavailability of poorly soluble drugs and low bioavailability drugs, using amphiphilic matrix, cyclodextrins and superdisintegrants.
Technologie MOR
Modified release therapeutic system to control gastrointestinal oral release, including colon target release and once-a-day administration for drugs with high dosing frequency.
Technologie LIMOR
Stabilized therapeutic system for immediate or modified oral release, including transformation of liquid raw materials into solid or semisolid drug products.
Entwicklung und Herstellung pharmazeutischer Darreichungsformen
Development and production of pharmaceutical dosage forms from laboratory to industrial scale according to Good Laboratory Practices and Good Manufacturing Practices.
Präklinische und klinische Studienunterstützung
Support for preclinical and clinical studies for Phase I-II clinical trials in compliance with Good Laboratory Practices and Good Clinical Practices.
Trust & reputation

ranQ Trust Score of Mogon Pharmaceuticals Sagl

Trust Score

No score yet

x

A published score requires a data basis of at least 50% and data from at least two criteria groups other than identity. Missing evidence: Review quality, Review volume, Review recency, Media authority

Data basis 54% · As of October 2026

Mogon Pharmaceuticals Sagl has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Mogon Pharmaceuticals Sagl scores 79.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.92.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Mogon Pharmaceuticals Sagl scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Mogon Pharmaceuticals Sagl scores 0.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.0.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%

The data basis is 54%, below the threshold at which ranQ publishes a score. Evidence is missing for: Review quality, Review volume, Review recency, Media authority. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Mogon Pharmaceuticals Sagl has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Mogon Pharmaceuticals Sagl in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Mogon Pharmaceuticals Sagl by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Mogon Pharmaceuticals Sagl to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Via Lungolago Motta 84
6815 Melide

At a glance

Legal form
Limited Liability Company
UID
CHE-389.086.306
Founded
2014 · 12 years
Last commercial register change
December 8, 2014
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AP
    Alpex Pharma SA
    Mezzovico
    FI
    Fondazione Istituto di Ricerche Farmacologiche Mario Negri (Suisse)
    Lugano
    GG
    GT Gain Therapeutics SA
    Lugano
    SS
    SAPHYRION Sagl
    Bioggio
    AS
    ALTRION Sagl
    Stabio
    GG
    GRG Gene Technology SA
    Contone
    SA
    SCIENCE ADVENTURE SAGL
    Lugano
    UB
    Ugo Basile R&D SA
    Lugano